Advertisement
Table 3 Immunophenotype and molecular analysis of biopsies from 19 patients with HV-LPD
| Case | CD3 | CD8 | CD4 | CD56 | TIA1 | CD30 | Ki67 | EBERs | TCR rearrangement |
|---|---|---|---|---|---|---|---|---|---|
| 1 | + | + | – | – | + | – | 30% | + | – |
| 2 | + | – | – | + | + | – | 60% | + | – |
| 3 | + | – | – | + | + | – | 30% | + | ND |
| 4 | + | – | + | – | + | P+ | 80% | + | – |
| 5 | + | + | – | – | + | ND | 30% | + | – |
| 6 | + | – | – | + | + | ND | 30% | + | – |
| 7 | + | + | – | – | + | – | 30% | + | – |
| 8 | + | – | – | + | + | P+ | 50% | + | ND |
| 9 | + | – | + | – | + | + | 70% | + | + |
| 10 | + | + | – | – | + | ND | 20% | + | + |
| 11 | + | + | – | – | + | – | 30% | + | + |
| 12 | + | – | – | + | + | – | 30% | + | ND |
| 13 | + | – | – | + | + | + | 70% | + | F |
| 14 | + | – | + | – | + | ND | 40% | + | + |
| 15 | + | – | – | + | + | – | 60% | + | – |
| 16 | + | – | + | – | + | P+ | 70% | + | + |
| 17 | + | – | + | – | + | + | 40% | + | + |
| 18 | + | – | + | – | + | – | 10% | + | + |
| 19 | + | – | + | – | + | – | 60% | + | – |
